• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲引起感染的肠球菌的抗菌药敏模式。欧洲耐万古霉素肠球菌研究小组。

Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.

作者信息

Schouten M A, Voss A, Hoogkamp-Korstanje J A

机构信息

University Hospital St. Radboud, Department of Medical Microbiology, 6500 HB Nijmegen, The Netherlands.

出版信息

Antimicrob Agents Chemother. 1999 Oct;43(10):2542-6. doi: 10.1128/AAC.43.10.2542.

DOI:10.1128/AAC.43.10.2542
PMID:10508041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC89517/
Abstract

In vitro susceptibilities of 4,208 enterococci (83% Enterococcus faecalis isolates, 13.6% Enterococcus faecium isolates, and 3.4% isolates of other species) from patients in 27 European countries towards 16 antibiotics were determined. High-level resistance to gentamicin varied by country (range, 1 to 49%; mean, 22.6% +/- 12. 3%) and per species (19.7% E. faecalis isolates, 13.6% E. faecium isolates, 3.4% by other species). Vancomycin resistance was detected in 0.06% E. faecalis, 3.8% E. faecium, and 19.1% isolates of other species. All enterococci were susceptible to LY 333328 and everninomicin, and 25% of E. faecalis isolates and 85% of other enterococci were susceptible to quinupristin-dalfopristin. The MIC of moxifloxacin and trovafloxacin for ciprofloxacin-susceptible E. faecalis at which 90% of the isolates were inhibited was 0.25 to 0.5 microg/ml.

摘要

对来自27个欧洲国家患者的4208株肠球菌(83%为粪肠球菌分离株,13.6%为屎肠球菌分离株,3.4%为其他菌种的分离株)进行了16种抗生素的体外药敏试验。对庆大霉素的高水平耐药性因国家而异(范围为1%至49%;平均为22.6%±12.3%),且因菌种不同而有所差异(粪肠球菌分离株中为19.7%,屎肠球菌分离株中为13.6%,其他菌种中为3.4%)。在粪肠球菌中检测到0.06%的万古霉素耐药,屎肠球菌中为3.8%,其他菌种中为19.1%。所有肠球菌对LY 333328和埃维霉素敏感,25%的粪肠球菌分离株和85%的其他肠球菌对奎奴普丁-达福普汀敏感。对环丙沙星敏感的粪肠球菌,90%的分离株被抑制时,莫西沙星和曲伐沙星的MIC为0.25至0.5微克/毫升。

相似文献

1
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.欧洲引起感染的肠球菌的抗菌药敏模式。欧洲耐万古霉素肠球菌研究小组。
Antimicrob Agents Chemother. 1999 Oct;43(10):2542-6. doi: 10.1128/AAC.43.10.2542.
2
[Evaluation of virulence factors in enterococcus species].[肠球菌属中毒力因子的评估]
Mikrobiyol Bul. 2017 Apr;51(2):101-114. doi: 10.5578/mb.53992.
3
Emergence of High-level Gentamicin Resistance among Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working.伊朗西南部烧伤患者临床分离株中高水平庆大霉素耐药性的出现:万古霉素仍然有效。
Pol J Microbiol. 2018;67(4):401-406. doi: 10.21307/pjm-2018-043.
4
Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.来自九个欧盟国家(EASSA 研究)健康牛、猪和鸡中肠球菌对抗菌药物的药敏性。
Vet Microbiol. 2018 Mar;216:168-175. doi: 10.1016/j.vetmic.2018.02.010. Epub 2018 Feb 10.
5
Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland.波兰小波兰省地区4家医院中肠球菌属菌株的分型
Adv Clin Exp Med. 2018 Jan;27(1):111-117. doi: 10.17219/acem/68265.
6
Susceptibility patterns of enterococci causing infections.引起感染的肠球菌的药敏模式。
Tohoku J Exp Med. 2004 Jan;202(1):23-9. doi: 10.1620/tjem.202.23.
7
Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark.丹麦社区人群、肉鸡和猪源粪肠球菌和屎肠球菌的抗菌药物耐药表型与耐药基因比较
Diagn Microbiol Infect Dis. 2000 Jun;37(2):127-37. doi: 10.1016/s0732-8893(00)00130-9.
8
Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).韩国临床分离株中莫匹罗星、达托霉素、利奈唑胺、奎奴普丁/达福普汀和替加环素对耐万古霉素肠球菌(VRE)的抗菌活性(1998年和2005年)
J Biochem Mol Biol. 2007 Nov 30;40(6):881-7. doi: 10.5483/bmbrep.2007.40.6.881.
9
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].[从尿液中分离出的肠球菌属的抗生素敏感性分析]
Przegl Lek. 2004;61(5):473-6.
10
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.北美和欧洲耐万古霉素肠球菌的抗菌药物耐药性及分子流行病学:哨兵抗菌监测项目报告
Diagn Microbiol Infect Dis. 2007 Jun;58(2):163-70. doi: 10.1016/j.diagmicrobio.2006.12.022. Epub 2007 Mar 26.

引用本文的文献

1
Vancomycin-resistant Enterococcus (VRE) isolates from dogs and cats in veterinary hospitals in Brazil.从巴西兽医医院的犬猫身上分离出的耐万古霉素肠球菌(VRE)菌株。
BMC Vet Res. 2025 Feb 25;21(1):99. doi: 10.1186/s12917-025-04557-7.
2
Evolutionary trajectories of β-lactam resistance in strains.菌株中β-内酰胺抗性的进化轨迹。
mBio. 2024 Dec 11;15(12):e0289724. doi: 10.1128/mbio.02897-24. Epub 2024 Nov 14.
3
Oral antimicrobial options for vancomycin-resistant isolates in urine culture.尿培养中耐万古霉素分离株的口服抗菌药物选择。
Bladder (San Franc). 2024 Sep 10;11(2):e21200008. doi: 10.14440/bladder.2024.0016. eCollection 2024.
4
Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than or in Patients With Cancer.癌症患者中除粪肠球菌或屎肠球菌外其他肠球菌属引起的血流感染的临床特征和基因组流行病学
Open Forum Infect Dis. 2024 May 17;11(6):ofae288. doi: 10.1093/ofid/ofae288. eCollection 2024 Jun.
5
Antimicrobial resistance of Escherichia coli, Enterobacter spp., Klebsiella pneumoniae and Enterococcus spp. isolated from the feces of giant panda.从大熊猫粪便中分离的大肠杆菌、肠杆菌属、肺炎克雷伯菌和肠球菌属的耐药性。
BMC Microbiol. 2022 Apr 14;22(1):102. doi: 10.1186/s12866-022-02514-0.
6
Successful treatment of aortic valve endocarditis caused by Enterococcus casseliflavus: a case report.成功治疗粪肠球菌致主动脉瓣心内膜炎 1 例报告
BMC Infect Dis. 2021 May 18;21(1):447. doi: 10.1186/s12879-021-06160-1.
7
Urban and agricultural soils in Southern California are a reservoir of carbapenem-resistant bacteria.南加州的城市和农业土壤是耐碳青霉烯类抗生素细菌的储库。
Microbiologyopen. 2020 Jun;9(6):1247-1263. doi: 10.1002/mbo3.1034. Epub 2020 Apr 3.
8
Antibiotic Resistance and Virulence Traits in Vancomycin-Resistant Enterococci (VRE) and Extended-Spectrum β-Lactamase/AmpC-producing (ESBL/AmpC) from Humans and Pets.来自人和宠物的耐万古霉素肠球菌(VRE)及产超广谱β-内酰胺酶/ AmpC酶(ESBL/AmpC)中的抗生素耐药性及毒力特征
Antibiotics (Basel). 2020 Mar 31;9(4):152. doi: 10.3390/antibiotics9040152.
9
High Level Aminoglycoside Resistance And Distribution Of The Resistance Genes In And From Teaching Hospital In Malaysia.马来西亚某教学医院中高水平氨基糖苷类耐药性及耐药基因的分布情况
Infect Drug Resist. 2019 Oct 21;12:3269-3274. doi: 10.2147/IDR.S219544. eCollection 2019.
10
High level aminoglycoside resistant enterococci in hospital-acquired urinary tract infections in Mansoura, Egypt.埃及曼苏拉医院获得性尿路感染中高水平氨基糖苷类耐药肠球菌
Germs. 2018 Dec 3;8(4):186-190. doi: 10.18683/germs.2018.1145. eCollection 2018 Dec.

本文引用的文献

1
Controlling glycopeptide-resistant enterococci.控制耐糖肽肠球菌
Clin Microbiol Infect. 1997;3(5):592-593. doi: 10.1111/j.1469-0691.1997.tb00321.x.
2
The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.氯霉素在治疗耐万古霉素肠球菌所致血流感染中的作用。
Clin Infect Dis. 1998 Nov;27(5):1259-65. doi: 10.1086/515002.
3
In vitro activities of 15 antimicrobial agents against clinical isolates of South African enterococci.15种抗菌剂对南非肠球菌临床分离株的体外活性
Antimicrob Agents Chemother. 1998 Oct;42(10):2752-5. doi: 10.1128/AAC.42.10.2752.
4
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium.LY333328与氨苄西林单独及联合使用对耐万古霉素屎肠球菌的抑制和杀菌活性及抗生素后效应比较
Antimicrob Agents Chemother. 1998 Oct;42(10):2564-8. doi: 10.1128/AAC.42.10.2564.
5
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.来自美国的耐万古霉素屎肠球菌分离株的特征及其对达福普汀-奎奴普汀的体外敏感性
Antimicrob Agents Chemother. 1998 May;42(5):1088-92. doi: 10.1128/AAC.42.5.1088.
6
Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.一种新型糖肽类抗生素(LY333328)对肠球菌及其他耐药革兰氏阳性菌的活性。
J Antimicrob Chemother. 1997 Sep;40(3):423-5. doi: 10.1093/jac/40.3.423.
7
Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.喹奴普丁-达福普汀对革兰氏阳性血流分离株的体外比较活性。
J Antimicrob Chemother. 1997 Aug;40(2):213-9. doi: 10.1093/jac/40.2.213.
8
Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.在粪肠球菌菌血症治疗期间出现对奎奴普丁/达福普汀耐药性增加的情况。
Clin Infect Dis. 1997 Jan;24(1):90-1. doi: 10.1093/clinids/24.1.90.
9
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.研究性糖肽类抗生素LY333328对肠球菌和葡萄球菌的体外活性。
Antimicrob Agents Chemother. 1996 Oct;40(10):2416-9. doi: 10.1128/AAC.40.10.2416.
10
Acidification of methyl-alpha-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis.α-D-甲基吡喃葡萄糖苷酸化试验:一种区分格氏肠球菌和鹑鸡肠球菌与粪肠球菌种组及粪肠球菌的有用试验。
J Clin Microbiol. 1996 Oct;34(10):2607-8. doi: 10.1128/jcm.34.10.2607-2608.1996.